Background: Although rectal tenesmus in patients with advanced cancer can have marked negative impact on quality of life, effective treatment has not yet been established. Case: A 71 -year-old man with an inoperable rectal cancer developed tenesmus 11 months after a colostomy. Tenesmus worsened over the following 3 months, and the patient suffered from involuntary straining every 5-15 minutes. After unsuccessful symptom control with radiotherapy to the primary lesion, we started oral amoxapine 25 mg that alleviated symptoms related to tenesmus. As the general condition deteriorated, however, oral intake became difficult. After the discontinuation of amoxapine, the tenesmus recurred even though intravenous administration of clomipramine was initiated. We started continuous infusion of intravenous lidocaine 200 mg/day which successfully relieved tenesmus. The dose of lidocaine was subsequently increased to 290 mg/day for worsening symptoms, which continued to control his distress caused by tenesmus until he died. Consideration/Conclusion: This is the first report that demonstrates the efficacy of oral amoxapine for rectal tenesmus with malignant tumor. After the discontinuation of amoxapine due to the inability of taking medications orally, symptoms remained under adequate control with infusional lidocaine until the patient died. Further studies are warranted to confirm our findings and to propose optimal use of medications in the management of rectal tenesmus.

This study was conducted to identify the needs of patients and their families based on surveys involving patients and bereaved families, and describe the process of producing a survey-based leaflet for health care professionals.Questionnaire surveys were conducted on 550 advanced cancer patients and 632 bereaved families in Hamamatsu, and 337 and 432 responses were collected. Opinions and requests regarding cancer treatment and palliative care were analyzed, and 378 meaning units were collapsed into six categories of requests to health professionals: “Share patient and family feelings and support decisions”; “Allow the patient to stay where he/she wants”; “Relieve physical discomfort as much as possible”; “Support to complete what family members want for the patient not to regret”; “Help patient and family have hope”, and; “Reduce concerns about opioids”. A leaflet for health care professionals about what they should take into the considerations was created based on patient and family surveys.